The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2011-12-01
|
| סדרה: | Oncology Reviews |
| נושאים: | |
| גישה מקוונת: | http://oncologyreviews.org/index.php/or/article/view/157 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|